OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negative advanced breast cancer
29 Sep 2020
OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negative advanced breast cancer
ESMO 2020 melanoma roundup
OncoAlert and ecancer weekly roundup for September 20 - 26, 2020
Nivolumab for oesophageal cancer following chemoradiation therapy
PROFound trial and other recent updates in prostate cancer
Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma
Managing multiple myeloma in a COVID-19 world
ESMO 2020 renal roundup
Exon 20 insertions in NSCLC - ESMO 2020
ESMO 2020: Lung cancer latest
Highlights from ESMO 2020
PARP inhibitors and their evolving role for the treatment of prostate cancer